We have located links that may give you full text access.
Low Anterior Resection Syndrome in a Reference North American Sample: Prevalence and Associated Factors.
Journal of the American College of Surgeons 2023 July 20
BACKGROUND: Low anterior resection syndrome(LARS) is a well described consequence of rectal cancer treatment. Studying the degreeto which bowel dysfunction exists in the general population may help to better interpret to what extent LARS is related to disease and/or cancer treatment. Currently, North American LARS normative data is lacking. The aim of this study was to describe the prevalence of bowel dysfunction, as measured by the LARS score, and quality of life(QoL) in a reference North American sample. Quality of life was measured and associations between participant characteristics and LARS were identified.
STUDY DESIGN: This was a single-institution cross-sectional study of asymptomatic adults who underwent screening and surveillance colonoscopies from 2018-2021 with no/benign endoscopic findings. Survey was conducted on select comorbidities, sociodemographic factors, LARS, and QoL. Outcomes were LARS and QoL. Multivariable linear regression accounting for a priori clinical factors associated with bowel dysfunction was performed.
RESULTS: Of 1,004 subjects approached, 502(50.0%) participated, and 135(26.9%) participants had major/minor LARS. On multiple linear regression, female gender (β=2.15, 95%CI 0.30,4.00), younger age (β=-0.10, 95%CI -0.18,-0.03), Caucasian ethnicity (β=2.45, 95%CI 0.15,4.74), and presence of at least one of the following factors: diabetes, depression, neurological disorder, or cholecystectomy (β=3.54, 95%CI 1.57,5.51) were independently associated with a higher LARS score. Individuals with LARS had lower global QoL, functional subscales and various symptom subscales scores.
CONCLUSIONS: Our study identified the baseline prevalence of LARS in asymptomatic adults who have not undergone a low anterior resection. This normative data will allow for more accurate interpretation of ongoing studies on LARS in North American rectal cancer patients.
STUDY DESIGN: This was a single-institution cross-sectional study of asymptomatic adults who underwent screening and surveillance colonoscopies from 2018-2021 with no/benign endoscopic findings. Survey was conducted on select comorbidities, sociodemographic factors, LARS, and QoL. Outcomes were LARS and QoL. Multivariable linear regression accounting for a priori clinical factors associated with bowel dysfunction was performed.
RESULTS: Of 1,004 subjects approached, 502(50.0%) participated, and 135(26.9%) participants had major/minor LARS. On multiple linear regression, female gender (β=2.15, 95%CI 0.30,4.00), younger age (β=-0.10, 95%CI -0.18,-0.03), Caucasian ethnicity (β=2.45, 95%CI 0.15,4.74), and presence of at least one of the following factors: diabetes, depression, neurological disorder, or cholecystectomy (β=3.54, 95%CI 1.57,5.51) were independently associated with a higher LARS score. Individuals with LARS had lower global QoL, functional subscales and various symptom subscales scores.
CONCLUSIONS: Our study identified the baseline prevalence of LARS in asymptomatic adults who have not undergone a low anterior resection. This normative data will allow for more accurate interpretation of ongoing studies on LARS in North American rectal cancer patients.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app